Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EP102 for acute migraine headache
ACTRN12625000333415Phase 2Recruiting
- Sponsor
- Epalex
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EP102 in migraine (3 arms), sponsored by Epalex. Started Oct 2025; status: recruiting.
02
Drugs
EP102
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12625000333415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000333415.